TherapeuticsMD (TXMD) Dividends payables (2010 - 2012)
TherapeuticsMD (TXMD) posted Dividends payables of $41359.0 for Q4 2012, little changed on a QoQ basis from $41359.0 in Q3 2011.
TherapeuticsMD (TXMD) Dividends payables (2010 - 2012) Analysis & Trends
TherapeuticsMD's Dividends payables history runs 3 years deep, the most recent figure standing at $41359.0 for Q4 2012.
- Quarterly Dividends payables changed N/A year-over-year to $41359.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $41359.0 (changed N/A YoY) and the FY2012 annual result came in at $41359.0, changed N/A from the prior year.
- Dividends payables was $41359.0 for Q4 2012 at TherapeuticsMD, roughly flat from $41359.0 in the prior quarter.
- Across five years, Dividends payables topped out at $41359.0 in Q4 2010 and bottomed at $41359.0 in Q4 2010.
- A 3-year average of $41359.0 and a median of $41359.0 in 2010 frame the typical range for Dividends payables.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 41,359.00 |
| Sep 30, 2011 | 41,359.00 |
| Jun 30, 2011 | 41,359.00 |
| Dec 31, 2010 | 41,359.00 |